NewCo News: Diasome Changes up Insulin Treatments in Diabetes Field

July 21, 2008

BioWorld briefs for Dec. 11, 2024.

Today's news in brief

BioWorld MedTech briefs for December 10, 2024.

Boryung invests $10M in Intuitive Machines for outer space R&D

Following its $60 million investment in Axiom Space Inc. last year, Boryung Co. Ltd. made a $10 million private placement in Intuitive Machines Inc. to grow its...

Phase II Huntington’s tie-up with Novartis could edge $3B for PTC

BioWorld

PTC Therapeutics Inc. said a “highly competitive process with several parties involved” led to the deal centered on the firm’s Huntington’s disease program with...

Illustration of cancer in the bile ducts

Elevar nabs Relay’s FGFR2 rare cancer drug in $500M deal

BioWorld

Elevar Therapeutics Inc. will license Relay Therapeutics Inc.’s “NDA-ready” bile duct cancer therapy, lirafugratinib (RLY-4008), through a potential $500 million...

Erik McNeal

ARTICLES

NewCo News: Diasome Changes up Insulin Treatments in Diabetes Field

Today's news in brief

Today's news in brief

Boryung invests $10M in Intuitive Machines for outer space R&D

Phase II Huntington’s tie-up with Novartis could edge $3B for PTC

Elevar nabs Relay’s FGFR2 rare cancer drug in $500M deal